SDZ.SW Stock — Price, Charts & Analysis

Sandoz Group AG (SDZ.SW) has a trailing P/E of 62.05x and a forward P/E of 20.30x. This places SDZ.SW in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

SDZ.SW trades with 62.05x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether SDZ.SW looks overvalued or undervalued.

SDZ.SW's P/E of 62.05x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

SDZ.SW's trailing EPS is CHF 1.19 and forward EPS is CHF 3.64. Reported earnings growth is -71.30%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Sandoz Group AG generated for each share. SDZ.SW's trailing EPS is CHF 1.19, and investors usually prefer EPS that is positive and growing over time.

Sandoz Group AG has a market cap of CHF 31.95B, making SDZ.SW a large-cap stock based on the current market value shown on Worldtickers.

SDZ.SW's latest stock price on Worldtickers is CHF 73.84. The latest move is CHF 0.24 or 0.33%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

SDZ.SW's quote includes a latest price of CHF 73.84. The market open is CHF 73.34. Previous close is CHF 73.60. The intraday range is CHF 73.18 to CHF 74.22.

SDZ.SW is up in the latest quote, with a move of CHF 0.24 or 0.33%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

SDZ.SW generated CHF 11.68B in trailing revenue. Revenue growth is 9.90%, which helps show whether demand is expanding or slowing.

SDZ.SW's revenue growth is 9.90%, which is a positive demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, SDZ.SW shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is CHF 646.00M.

Gross margin is 47.94%. Margins show how efficiently Sandoz Group AG turns revenue into profit.

Sandoz Group AG carries CHF 6.20B and holds CHF 2.27B in cash.

SDZ.SW holds CHF 2.27B on its balance sheet.

SDZ.SW's book value per share is CHF 16.78.

Yes, Sandoz Group AG pays a dividend of CHF 0.80 per share annually. The dividend yield is 109.00%. The payout ratio is 68.81%.

SDZ.SW's dividend yield is 109.00%. Its payout ratio is 68.81%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for SDZ.SW. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Sandoz Group AG's investor relations materials.

Institutions hold 50.56% of SDZ.SW shares. Insiders hold 4.19% of shares. Ownership mix helps investors understand how much of Sandoz Group AG is held by professional investors and company insiders.

SDZ.SW has 432.69M shares outstanding. Float shares are 416.44M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for SDZ.SW, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for SDZ.SW is CHF 3.64. Earnings growth is -71.30%. Revenue growth is 9.90%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

SDZ.SW's trailing EPS is CHF 1.19. Forward EPS is CHF 3.64. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

SDZ.SW is in the Healthcare sector. Its earnings multiple is 62.05x. Its latest displayed growth metric is 9.90%. Compare these figures with sector peers before deciding whether Sandoz Group AG is stronger or weaker than average.

SDZ.SW trades at CHF 73.84. The stock trades at 62.05x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Sandoz Group AG's fundamentals.

SDZ.SW risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.49, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

SDZ.SW should be compared with companies in Drug Manufacturers - Specialty & Generic. Its earnings multiple is 62.05x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Sandoz Group AG (SDZ.SW) operates in Healthcare, specifically Drug Manufacturers - Specialty & Generic. Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration with Shanghai Henliu

SDZ.SW trades on Swiss. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

SDZ.SW stock is priced in CHF on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Sandoz Group AG's official website listed on Worldtickers is www.sandoz.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Sandoz Group AG employs about 20K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Sandoz Group AG is headquartered in Basel, Switzerland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

SDZ.SW is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

SDZ.SW has traded between CHF 43.86 and CHF 75.90 over the past 52 weeks. At CHF 73.84, it is 2.71% below the high and 68.35% above the low. The 52-week range helps gauge long-term price momentum.

SDZ.SW is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is CHF 69.10 and its 200-day moving average is CHF 63.24.

SDZ.SW's RSI is 62.05. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

SDZ.SW's latest RSI reading is 62.05, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for SDZ.SW is near CHF 63.22. Key resistance is near CHF 75.90. Breaks above resistance or below support can change the short-term technical setup.

SDZ.SW's nearest reported support level is CHF 63.22. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

SDZ.SW's nearest reported resistance level is CHF 75.90. A breakout above resistance can improve momentum, especially when volume confirms the move.

SDZ.SW trades about 751.5K shares daily on average. The latest displayed volume is 660.11K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

SDZ.SW's MACD is 0.41, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

SDZ.SW is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 62.05 (neutral). MACD is bullish. Nearest support is around CHF 63.22. Resistance is around CHF 75.90. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is CHF 70.05 (5.41% from price). MA50 is CHF 69.10 (6.86% from price). MA200 is CHF 63.24 (16.75% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. SDZ.SW's MA20 is CHF 70.05. MA50 is CHF 69.10. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

SDZ.SW's pivot is near CHF 73.89. Support is near CHF 63.22. Resistance is near CHF 75.90. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for SDZ.SW is near CHF 71.62. The next upper resistance zone is near CHF 75.90. These levels help define risk and possible follow-through zones after a breakout or breakdown.

SDZ.SW's Bollinger range is roughly CHF 62.33 to CHF 77.77. Band width is near 22.04%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

SDZ.SW's ATR-based typical daily range is about 2.94%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 660.11K shares. Average volume is about 751.5K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

SDZ.SW's all-time high shown on Worldtickers is CHF 75.90. Its all-time low is CHF 22.70. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

SDZ.SW has a beta of 0.49, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.